Programming Cancer With AI To Self-Destruct | Cyriac Roeding | TEDxPaloAlto
TEDx Talks44.4M subscribers
TBPN Network: Earli announces another $44M in funding (total now: $104M) from former J&J CEO Alex Gorsky & his family office Alderline Group, Accentures Ventures, Han River Partners (S Korea), along with prior investors a16z, Khosla, Perceptive Advisors.
NPR BioTech Nation - Podcast: Can Cancer Cells Be Turned Against Themselves? Cyriac Roeding & Dr. David Suhy, Co-Founders, Earli
White House Cancer Moonshot Fact Sheet : Earli highlighted as a key initiative for future cancer treatment technologies.
S. Korea #1 Business Newspaper Maeil: Ordering Cancer Cells to "Self-Destruct"? U.S. Biotech Firm Unveils Breakthrough Gene Technology (in Korean language/translated).
The Scientist - Interview : Turning Tumors Against Themselves From the Inside.
BiotechTV: How Earli AI - designed Genetic Switches That Turn On Only in Cancer
Fast Company feature story: The fundamental change Earli may bring to patients: A cancer genius died from cancer. His startup is getting revenge.
Genetic Engineering & Biotechnology News: How Earli built a world-class team to solve one of the most difficult science problems: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers.
Drug Discovery Trends: Earli's newest partnership. Earli and Accenture partner in quest to turn cancer against itself .
Biospace - Opinion: Trump Must Make Biotech Innovations a National Priority
Newsweek Opinion: Why early detection misses the mark without Early Treatment: One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths.
CGT Live: Using DNA Nanoplasmids as a Diagnostic Tool in Cancer .
Entrepreneur: The Heartbreaking Loss of a Child to Cancer Brought These 3 Founders Together.
Pharmaceutical Technology: Accenture Invests in Earli's Cancer Detection Tech.
Sydney Morning Herald: Earli’s human trial: Australia’s ‘high quality’ clinical trials lure Silicon Valley cancer fighting company.
World Economic Forum selects Earli: 100 firms worldwide to join its Global Innovator community.
Fast Company: Earli the only early cancer detection firm in list of 2021 World Changing Ideas.
WIRED Feature: How Earli forces cancer to draw a “map” to itself: A Proactive Way to Detect Cancer at Its Earliest Stages.
The Atlantic: Medical Revolution Too Late for the Man Who Started It .
Nikkei: Cancer treatment: control over early detection (in Japanese language).
Tough Tech Today: Co-founder Cyriac Roeding tells the story of Earli in a video podcast.
S. Korea: Medical Newspaper: A new frontier in cancer treatment: controlling cancer cells and making them self-destruct (in Korean Language)
German BusinessWeek (Wirtschaftswoche): tells the story and breakthrough potential of Earli(in German language) .
Forbes: This Company Raised $40 Million To Make Tumors Reveal Themselves .
Business Wire: Earli raises $40M in Series A funding led by Khosla Ventures, with Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital, two years after its $19.5M Seed round led by Andreessen Horowitz’s Bio Fund.
Stat News: Sam Gambhir described how new ways to detect cancer early will help pave the way for precision health.
TEDxPalo Alto | Programming Cancer With AI To Self-Destruct| Cyriac Roeding
At TEDx Palo Alto, Earli CEO Cyriac Roeding shares a vision for transforming cancer detection and treatment through AI, synthetic biology, and engineered biomarkers.
Cyriac's TIME piece breaks down how AI is finally solving cancer's oldest problem — telling tumor cells apart from healthy ones — and why catching it earlier changes everything.
In a Davos 2026 conversation with SandboxAQ, Cyriac Roeding explains how Earli uses AI-designed genetic switches and genomic insights to enable more precise, targeted, and effective cancer therapies.
Cyriac Roeding, CEO and CoFounder of Earli, argues in his BioSpace piece that U.S. leadership in biotech depends on making innovation a national priority.